Article

Treating male UTI for >7 days doesn't cut recurrence

A study of more than 33,000 outpatient male veterans suggests that a duration of antimicrobial treatment of more than 7 days for a urinary tract infection (UTI) does not reduce the risk of early or late recurrence compared to a shorter duration (7 days or less) of treatment.

Related Videos
1 expert in this video
1 expert is featured in this series.
1 expert is featured in this series.
Related Content
Site Logo
April 29th 2025

Advancing Patient Care: Innovations in Bladder Cancer

Sponsored by Pfizer
Pearls & Perspectives: Martin Kathrins, MD, on MED3000 and learning from failed trials
April 28th 2025

Pearls & Perspectives: Martin Kathrins, MD, on MED3000 and learning from failed trials

Amy M. Pearlman, MD Martin Kathrins, MD
Kathrins discusses the intricacies of leading a clinical trial and why "negative" trials are important to informing care strategies.
Benign Prostatic Hyperlasia | Image Credit: © Judith - stock.adobe.com
April 28th 2025

Investigational ProVee System impresses in phase 3 trial in BPH

Benjamin P. Saylor
No device- or procedure-related serious AEs were observed through 12 months across the entire study population
Speaking of Urology: Melissa Kaufman, MD, on AUA’s new guideline on genitourinary syndrome of menopause
April 28th 2025

Speaking of Urology: Melissa Kaufman, MD, on AUA’s new guideline on genitourinary syndrome of menopause

Melissa Kaufman, MD, PhD, FACS
In this episode, guideline chair Melissa Kaufman, MD, PhD, FACS, highlights key points from the new AUA GSM guideline and illustrates its impact for clinical management of this condition.
Kidney stones | Image Credit: © airborne77 - stock.adobe.com
April 28th 2025

CVAC 2.0 demonstrates efficacy for clearing stones less than 2 cm

Benjamin P. Saylor
The investigators reported a median stone clearance of 96.44%.
Skyler Howell, MD | Credit: X.com
April 28th 2025

AUA 2025: GLP-1 RAs could improve sperm count in overweight men

Patrick Campbell
New research reveals GLP-1 receptor agonists may enhance sperm counts in overweight men.
© 2025 MJH Life Sciences

All rights reserved.